Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nagelmeier

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Der Nervenarzt|May 12, 2007
[Type I neurofibromatosis and megadolichobasilar artery]C Roth, T Gaiser, I Nagelmeier, et al.
Der Pathologe|February 14, 2009
[ErbB2 diagnostics in breast cancer--an update]J Rüschoff, I Nagelmeier, M Hofmann, et al.
Der Pathologe|May 6, 2010
[Her2 testing in gastric cancer. What is different in comparison to breast cancer?]J Rüschoff, I Nagelmeier, G Baretton, et al.
Journal of Clinical Pathology|October 29, 2009
EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancerM Varella-Garcia, J Diebold, D A Eberhard, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Der Nervenarzt|May 12, 2007
[Type I neurofibromatosis and megadolichobasilar artery]C Roth, T Gaiser, I Nagelmeier, et al.
Der Pathologe|February 14, 2009
[ErbB2 diagnostics in breast cancer--an update]J Rüschoff, I Nagelmeier, M Hofmann, et al.
Der Pathologe|May 6, 2010
[Her2 testing in gastric cancer. What is different in comparison to breast cancer?]J Rüschoff, I Nagelmeier, G Baretton, et al.
Journal of Clinical Pathology|October 29, 2009
EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancerM Varella-Garcia, J Diebold, D A Eberhard, et al.
Pageof 1